Execution Phase Of Apoptosis Pathway Bioinformatics
Apoptosis is a form of programmed cell death, which can be either a developmental process or a response from the human immune system. During the execution phase of apoptosis, the cell undergoes changes including cell shrinkage, chromosomal condensation, nuclear and chromosomal DNA fragmentation, and blebbing. In particular, caspase-3 cleaves the DNAase inhibitor as well as proteins of the cytoskeleton, facilitating the process of cellular fragmentation. The execution phase occurs after the cells fully commit to die, and once this phase is initiated, cell death occurs very quickly. A preliminary step in this phase is microtubule disassembly through the depolymerization of actomyosin filaments, which helps to disperse cellular fragments and keep the plasma membrane, which results in the cellular packaging that keeps the apoptosis from becoming an inflammatory event. The final event of apoptosis is the phagocytosis of the apoptotic bodies by another cell, avoiding inflammation and any other adverse reactions to the cellular particles.
Execution Phase Of Apoptosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Execution Phase Of Apoptosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 2218 products for the study of the Execution Phase Of Apoptosis Pathway that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.